EVO

Evotec SE

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$1.53

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %10.2 / %30

Non-compliant assets / Total market cap %2.8 / %30

Non-compliant income / Total income %0.3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics.